MA28674B1 - Préparation de prégabaline et de composés apparentés - Google Patents

Préparation de prégabaline et de composés apparentés

Info

Publication number
MA28674B1
MA28674B1 MA29548A MA29548A MA28674B1 MA 28674 B1 MA28674 B1 MA 28674B1 MA 29548 A MA29548 A MA 29548A MA 29548 A MA29548 A MA 29548A MA 28674 B1 MA28674 B1 MA 28674B1
Authority
MA
Morocco
Prior art keywords
preparation
related compounds
pregabalin
warner
aminomethyl
Prior art date
Application number
MA29548A
Other languages
English (en)
Inventor
Shanghui Hu
Carlos Alberto Martinez
Junhua Tao
William Eugene Tully
Patrick Gerard Thomas Kelleher
Yves Rene Dumond
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295367&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA28674(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MA28674B1 publication Critical patent/MA28674B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/12—Formation of amino and carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/001—Amines; Imines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/002—Nitriles (-CN)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

DEPOSANT Société dite : WARNER-LAMBERT COMPANY LLC REVENDICATION DE PRIORITES US 21 Juin 2004 60/581,671 US 18 Novembre 2004 60/629,034 Voir en annexe le titre de l'invention et le texte de l'abrégé Préparation de prégabaline et de composés apparentés Des matériels et méthodes pour la préparation de l'acide (S)-(+}-3-aminométhyl-5-méthylhexanoïque et de composés structuralement apparentés par résolution cinétique enzymatique sont décrits.
MA29548A 2004-06-21 2006-12-21 Préparation de prégabaline et de composés apparentés MA28674B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58167104P 2004-06-21 2004-06-21
US62903404P 2004-11-18 2004-11-18

Publications (1)

Publication Number Publication Date
MA28674B1 true MA28674B1 (fr) 2007-06-01

Family

ID=35295367

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29548A MA28674B1 (fr) 2004-06-21 2006-12-21 Préparation de prégabaline et de composés apparentés

Country Status (32)

Country Link
US (4) US20050283023A1 (fr)
EP (1) EP1831154B1 (fr)
JP (5) JP4174551B2 (fr)
KR (3) KR100847927B1 (fr)
CN (2) CN102102114B (fr)
AP (1) AP2466A (fr)
AR (1) AR049446A1 (fr)
AT (1) ATE455093T1 (fr)
AU (1) AU2005256945B2 (fr)
BR (1) BRPI0512347B8 (fr)
CA (1) CA2571040C (fr)
CR (2) CR8765A (fr)
CY (1) CY1110337T1 (fr)
DE (1) DE602005018965D1 (fr)
DK (1) DK1831154T3 (fr)
EA (3) EA200800909A1 (fr)
ES (1) ES2336014T3 (fr)
GE (1) GEP20104895B (fr)
HR (1) HRP20100054T1 (fr)
IL (1) IL179614A0 (fr)
MA (1) MA28674B1 (fr)
ME (1) ME01067B (fr)
MX (1) MXPA06014228A (fr)
NO (1) NO338097B1 (fr)
NZ (1) NZ552220A (fr)
PL (1) PL1831154T3 (fr)
PT (1) PT1831154E (fr)
RS (1) RS51210B (fr)
SI (1) SI1831154T1 (fr)
TW (6) TWI396743B (fr)
UA (1) UA83575C2 (fr)
WO (1) WO2006000904A2 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001876A (en) 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
US7417165B2 (en) 2005-04-06 2008-08-26 Teva Pharmaceutical Industries Ltd. Crystalline forms of pregabalin
US7488846B2 (en) 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
WO2006110783A2 (fr) * 2005-04-11 2006-10-19 Teva Pharmaceutical Industries Ltd. Procede de fabrication de (s)-pregabaline
WO2006122259A1 (fr) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Resolution optique de l'acide 3-carbamoylmethyl-5-methyl hexanoique
KR100893312B1 (ko) 2005-05-10 2009-04-15 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린 및 이의 염의 제조 방법
KR20070067077A (ko) 2005-05-10 2007-06-27 테바 파마슈티컬 인더스트리즈 리미티드 이소부틸글루타르산을 함유하지 않는 프레가발린 및 이의제조 방법
CZ297970B6 (cs) * 2005-08-10 2007-05-09 Zentiva, A. S Zpusob výroby (S)-3-(aminomethyl)-5-methyl-hexanové kyseliny (pregabalinu)
WO2007035890A1 (fr) 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. Synthese asymetrique de l'acide (s)-(+)-3-(aminomethyl)-5-methylhexanoique
WO2007139933A2 (fr) 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Procédés pour la préparation d'acide r-(+)-3-(carbamoyl méthyl)-5-méthylhexanoïque et de sels de celui-ci
EP2071032A3 (fr) 2006-05-31 2009-07-08 Teva Pharmaceutical Industries Ltd Utilisation d'une résolution enzymatique pour la préparation d'intermédiaires de la prégabaline
US20080015385A1 (en) * 2006-05-31 2008-01-17 Lilach Hedvati Preparation of (S)-pregabalin-nitrile
WO2008118427A2 (fr) 2007-03-22 2008-10-02 Teva Pharmaceutical Industries Ltd. Synthèse de l'acide (s)-(+)-3-(aminométhyl)-5-méthylhexanoïque
JP5157576B2 (ja) 2007-05-14 2013-03-06 住友化学株式会社 光学活性２−アルキル−１，１，３−トリアルコキシカルボニルプロパンの製造方法
EP1992609A1 (fr) * 2007-05-14 2008-11-19 Dipharma Francis S.r.l. Processus de préparation d'acide (S)(+)-3-(aminomethyl)-5-methylhexanoique
KR100846419B1 (ko) * 2007-08-10 2008-07-15 한국과학기술원 프레가발린의 신규한 제조 방법
US20090062393A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched pregabalin
KR20090101462A (ko) * 2007-10-03 2009-09-28 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린-4-엘리미네이트, 프레가발린 5-엘리미네이트, 기준 마커 및 표준물로서의 이들의 용도, 및 이들을 낮은 수준으로 함유하는 프레가발린의 제조 방법
ITMI20072262A1 (it) * 2007-12-03 2009-06-04 Dipharma Francis Srl Procedimento per la preparazione di acido (s)(+)-3-(amminometil)-5-metilesanoico
WO2009087674A2 (fr) * 2007-12-18 2009-07-16 Watson Pharma Private Limited Procédé perfectionné pour la préparation de (s)-prégabaline
CA2710152A1 (fr) * 2007-12-26 2009-07-02 Generics (Uk) Limited Procedes de preparation de la pregabaline
SG176464A1 (en) * 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
KR20110025917A (ko) 2008-05-21 2011-03-14 산도즈 아게 ５－메틸－３－니트로메틸－헥산산 에스테르의 입체선택적 효소 가수분해 방법
US20090312560A1 (en) * 2008-06-10 2009-12-17 Lambertus Thijs Processes for making pregabalin and intermediates therefor
US20100087525A1 (en) * 2008-06-23 2010-04-08 Lilach Hedvati Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester
WO2010070593A2 (fr) 2008-12-19 2010-06-24 Pfizer Ireland Pharmaceuticals Esters de malonate
IT1394292B1 (it) 2009-05-07 2012-06-06 Dipharma Francis Srl Procedimento per la sintesi di pregabalina
WO2011141923A2 (fr) 2010-05-14 2011-11-17 Lupin Limited Synthèse améliorée d'un ester alkylique optiquement pur de l'acide (s) - 3-cyano-5-méthyl-hexanoïque, intermédiaire de la (s)-prégabaline
WO2012025861A1 (fr) 2010-08-23 2012-03-01 Pfizer Manufacturing Ireland Procédé de préparation de dérivés d'acide (s)-3-cyano-5-méthylhexanoïque et de prégabaline
WO2012059797A1 (fr) * 2010-11-04 2012-05-10 Lupin Limited Procédé de synthèse de la (s)-prégabaline
KR101306585B1 (ko) * 2011-04-14 2013-09-10 한국외국어대학교 연구산학협력단 프레가발린의 제조방법
CN102952057B (zh) * 2012-11-07 2015-09-09 浙江普洛家园药业有限公司 一种4-异丁基吡咯烷-2-酮的制备方法
JP6225490B2 (ja) * 2013-05-31 2017-11-08 大日本印刷株式会社 医薬品包装体
US10076550B2 (en) * 2014-06-25 2018-09-18 Council Of Scientific & Industrial Research Synergistic pharmaceutical composition for gastroinestinal disorders
WO2016075082A1 (fr) 2014-11-10 2016-05-19 Sandoz Ag Amination réductrice stéréosélective d'aldéhydes alpha-chiraux au moyen d'ω-transaminases pour la synthèse de précurseurs de la prégabaline et du brivaracétam
CN104557576B (zh) * 2014-12-19 2019-07-19 浙江华海药业股份有限公司 一种高纯度普瑞巴林的制备方法
CN105348125A (zh) * 2015-11-26 2016-02-24 太仓运通生物化工有限公司 一种以异戊醛为原料合成普瑞巴林的方法
CN107445864B (zh) * 2017-08-09 2020-01-17 无锡殷达尼龙有限公司 一种纯化长碳链氰基酸产物的方法
CN108358799B (zh) * 2018-04-24 2020-11-10 贵州师范大学 一种普瑞巴林的制备方法
CN109503403B (zh) * 2018-12-21 2021-11-16 卓和药业集团股份有限公司 一种普瑞巴林的拆分方法
CN113248416B (zh) * 2020-02-10 2024-03-26 江西博腾药业有限公司 1-((苄氧基)羰基)-4-乙基吡咯烷-3-羧酸的制备方法及其应用
EP4103168A4 (fr) * 2020-02-14 2024-04-24 Council Of Scientific & Industrial Research Procédé de préparation d'acides gamma-amino-butyriques et de leurs analogues
CN111205288B (zh) 2020-02-19 2021-03-30 四川大学 一种(1S,12bS)内酰胺酯化合物的合成方法
CN113651717B (zh) * 2021-08-05 2024-08-30 浙江工业大学 一种光学纯异丁基丁二腈的消旋方法
CN113880724A (zh) * 2021-12-06 2022-01-04 南京桦冠生物技术有限公司 一种3-(2-氨基苯基)-2-丙烯酸酯的制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125583A (en) * 1964-03-17 Hjnc oxchaxohxchc o oh
US637767A (en) * 1899-09-25 1899-11-28 Gaylard W Denyes Grain-drill.
SU452196A1 (ru) * 1973-02-12 2001-09-20 Филиал Всесоюзного Научно-Исследовательского Химико-Фармацевтического Института Им. Серго Орджоникидзе СПОСОБ ПОЛУЧЕНИЯ γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ
JPS60338B2 (ja) * 1980-12-16 1985-01-07 日本新薬株式会社 酪酸誘導体の製法
US4428887A (en) * 1982-07-14 1984-01-31 Monsanto Company Method of producing mono-substituted terminal diesters
US5618710A (en) * 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5616793A (en) * 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
DE19623142A1 (de) * 1996-06-10 1997-12-11 Huels Chemische Werke Ag Enantiomerenangereicherte, durch einen tertiären Kohlenwasserstoffrest substituierte Malonsäuremonoester sowie deren Herstellung
US6001876A (en) * 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
JPH10245369A (ja) * 1997-03-03 1998-09-14 Ajinomoto Co Inc セリン誘導体の製造方法
US6329429B1 (en) * 1997-06-25 2001-12-11 Warner-Lambert Company Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
US6194459B1 (en) * 1997-08-19 2001-02-27 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
RU2143002C1 (ru) * 1997-12-24 1999-12-20 Акционерное общество открытого типа "Мосагроген" СПОСОБ ПОЛУЧЕНИЯ γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ
JP2002520286A (ja) * 1998-07-09 2002-07-09 ワーナー−ランバート・カンパニー Ｇａｂａ類縁体及びカフェインを含んでなる組成物
US6306910B1 (en) * 1998-07-09 2001-10-23 Warner-Lambert Company Use of Gaba-analogues for treating insomnia
KR100697734B1 (ko) * 1998-10-16 2007-03-22 워너-램버트 캄파니 엘엘씨 조증 및 양극성 장애 치료용 제약 조성물
SI1250311T1 (en) * 2000-01-27 2004-10-31 Warner-Lambert Company Asymmetric synthesis of pregabalin
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6931007B2 (en) * 2001-07-25 2005-08-16 Longboard, Inc. System and method of serving data messages
EP1333087A1 (fr) * 2002-02-05 2003-08-06 Avantium International B.V. Agrégats réticulés d'enzymes et agent de réticulation
US20030225149A1 (en) * 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
FR2849024B1 (fr) * 2002-12-20 2007-11-02 Aventis Pharma Sa Nouveaux composes chiraux derives d'esters de l'acide hexanoique, procede et intermediaires de preparation, utilisation a la synthese de l'acide 2-(bromomethyl)2-ethyl hexanoique chiral
JP2006061112A (ja) * 2004-08-30 2006-03-09 Sumitomo Chemical Co Ltd 光学活性な２−（シクロペンチルメチル）−マロン酸モノエステルの製造方法
EP2071032A3 (fr) * 2006-05-31 2009-07-08 Teva Pharmaceutical Industries Ltd Utilisation d'une résolution enzymatique pour la préparation d'intermédiaires de la prégabaline

Also Published As

Publication number Publication date
EP1831154B1 (fr) 2010-01-13
WO2006000904A2 (fr) 2006-01-05
ATE455093T1 (de) 2010-01-15
NO20065329L (no) 2006-12-19
JP4777332B2 (ja) 2011-09-21
AU2005256945B2 (en) 2008-11-13
EA011765B1 (ru) 2009-06-30
PT1831154E (pt) 2010-02-19
HRP20100054T1 (hr) 2010-05-31
UA83575C2 (uk) 2008-07-25
JP2008088191A (ja) 2008-04-17
TW200604139A (en) 2006-02-01
TWI357405B (en) 2012-02-01
PL1831154T3 (pl) 2010-05-31
US8044227B2 (en) 2011-10-25
KR100847928B1 (ko) 2008-07-22
CR20110483A (es) 2011-10-24
CA2571040A1 (fr) 2006-01-05
US8134023B2 (en) 2012-03-13
KR20080015152A (ko) 2008-02-18
JP2008110985A (ja) 2008-05-15
CY1110337T1 (el) 2015-01-14
KR100847929B1 (ko) 2008-07-22
CN1972904B (zh) 2011-02-02
US20110065168A1 (en) 2011-03-17
JP4966183B2 (ja) 2012-07-04
US20090042262A1 (en) 2009-02-12
GEP20104895B (en) 2010-02-25
WO2006000904A3 (fr) 2006-04-27
TW200900375A (en) 2009-01-01
EA200800909A1 (ru) 2008-08-29
HK1104024A1 (en) 2008-01-04
AR049446A1 (es) 2006-08-02
NZ552220A (en) 2010-08-27
TWI377191B (en) 2012-11-21
SI1831154T1 (sl) 2010-03-31
TWI402248B (zh) 2013-07-21
US20120015412A1 (en) 2012-01-19
AU2005256945A1 (en) 2006-01-05
AP2466A (en) 2012-09-17
IL179614A0 (en) 2007-05-15
EP1831154A2 (fr) 2007-09-12
NO338097B1 (no) 2016-08-01
CN102102114A (zh) 2011-06-22
CA2571040C (fr) 2009-09-15
CN102102114B (zh) 2013-08-14
EA200602099A1 (ru) 2007-04-27
TWI399361B (zh) 2013-06-21
AP2006003846A0 (en) 2006-12-31
EA200800908A1 (ru) 2008-12-30
JP2008504252A (ja) 2008-02-14
HK1161307A1 (en) 2012-08-24
JP4800346B2 (ja) 2011-10-26
JP2009022272A (ja) 2009-02-05
TW200846306A (en) 2008-12-01
TW200902481A (en) 2009-01-16
ES2336014T3 (es) 2010-04-07
US7838686B2 (en) 2010-11-23
MXPA06014228A (es) 2007-02-14
BRPI0512347B8 (pt) 2021-05-25
BRPI0512347A (pt) 2008-03-04
EA015418B1 (ru) 2011-08-30
JP2008133289A (ja) 2008-06-12
CR8765A (es) 2008-01-02
TWI396743B (zh) 2013-05-21
KR100847927B1 (ko) 2008-07-22
TWI405747B (zh) 2013-08-21
DK1831154T3 (da) 2010-04-12
JP4782101B2 (ja) 2011-09-28
TW200846474A (en) 2008-12-01
KR20080015153A (ko) 2008-02-18
DE602005018965D1 (de) 2010-03-04
ME01067B (me) 2012-10-20
US20050283023A1 (en) 2005-12-22
BRPI0512347B1 (pt) 2018-03-20
TW200846307A (en) 2008-12-01
JP4174551B2 (ja) 2008-11-05
CN1972904A (zh) 2007-05-30
KR20080015524A (ko) 2008-02-19
RS51210B (sr) 2010-12-31

Similar Documents

Publication Publication Date Title
MA32104B1 (fr) Dérivés d'oxime en tant qu'inhibiteurs de hsp90
BRPI0512347A (pt) preparação da pregabalina e compostos relacionados
WO2008036653A3 (fr) N-hydroxyamidinohétérocycles modulateurs de l'indoléamine 2,3-dioxygénase
MA31849B1 (fr) Nouveaux dérivés de pyrimidine
TW200719892A (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
MXPA05012026A (es) Compuestos de azaindol como inhibidores de cinasa.
WO2008068615A8 (fr) Formes cristallines de l'acide (3s)-3-[n-(n'-(2-tert-butyphényl)oxamyl)alaninyl]amino-5-(2',3',5',6'-tétrafluorophénoxy)-4-oxopentanoïque
WO2008127646A8 (fr) Procédés à base de transaminase utilisés dans la préparation de la prégabaline
PT2344130E (pt) Composições tópicas farmacêuticas
MA32170B1 (fr) Nouveaux derives d'aminomethylbenzene
WO2008032227A3 (fr) Formulations topiques de composés contenant du tellure
WO2008151460A3 (fr) Composés de refroidissement
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
WO2006133523A3 (fr) Compositions de peroxydase antimicrobiennes ameliorees
WO2004033442A3 (fr) Nouveaux taxanes, leurs modes d'utilisation et leurs procedes de preparation
EP1941799A3 (fr) Compositions nematicides
WO2007020295A3 (fr) Micro-organismes a rendement ameliore destines a la synthese de la methionine
MY139291A (en) Use of 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5-tetramethylene-()3-dihydrofuran-2-one for controlling psyllids
WO2009055084A3 (fr) Compositions de vitamine c
WO2005118564A3 (fr) Methodes de synthese du milnacipran et de ses homologues
EA200601390A1 (ru) Композиции модафинила
EA201101179A1 (ru) Молекула нуклеиновой кислоты биосинтетического кластера, кодирующая нерибосомальные пептидсинтазы, и ее применение
GT200500358A (es) Compuestos organicos
WO2009057954A3 (fr) Composition pour le traitement de la stéatose hépatique
CA2680497C (fr) Formes cristallines de la 2-[2-chloro-4-methylsulfonyl-3-(2,2,2-trifluoroethoxymethyl)benzoyle]cyclohexane-1,3-dione